Risk and clinical outcomes of COVID-19 in patients with rheumatic diseases compared with the general population: a systematic review and meta-analysis
Author:
Publisher
Springer Science and Business Media LLC
Subject
Immunology,Immunology and Allergy,Rheumatology
Link
http://link.springer.com/content/pdf/10.1007/s00296-021-04803-9.pdf
Reference52 articles.
1. Wang C, Horby PW, Hayden FG, Gao GF (2020) A novel coronavirus outbreak of global health concern. Lancet (London, England) 395(10223):470–473. https://doi.org/10.1016/S0140-6736(20)30185-9
2. Sun J, Chen X, Zhang Z et al (2020) Forecasting the long-term trend of COVID-19 epidemic using a dynamic model. Sci Rep 10(1):21122. https://doi.org/10.1038/s41598-020-78084-w
3. Goyal R, Bulua AC, Nikolov NP, Schwartzberg PL, Siegel RM (2009) Rheumatologic and autoimmune manifestations of primary immunodeficiency disorders. Curr Opin Rheumatol 21(1):78–84. https://doi.org/10.1097/BOR.0b013e32831cb939
4. D’Antiga L (2020) Coronaviruses and immunosuppressed patients: the facts during the third epidemic. Liver Transplant 26(6):832–834. https://doi.org/10.1002/lt.25756
5. Au K, Reed G, Curtis JR et al (2011) High disease activity is associated with an increased risk of infection in patients with rheumatoid arthritis. Ann Rheum Dis 70(5):785–791. https://doi.org/10.1136/ard.2010.128637
Cited by 72 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Clinical Characteristics, Prognostic Factors, and Outcomes of COVID-19 in Autoimmune Rheumatic Disease Patients: A Retrospective Case–Control Study from Astana, Kazakhstan;Medicina;2024-08-23
2. COVID-19 in patients with rheumatic diseases: frequency and course;Medical alphabet;2024-07-21
3. THE COURSE OF BEHÇET’S DISEASE FOLLOWING COVID-19 DIAGNOSIS: A LARGE RETROSPECTIVE COHORT STUDY;Journal of Istanbul Faculty of Medicine / İstanbul Tıp Fakültesi Dergisi;2024-07-04
4. Outcomes of COVID-19 re-infections: a single-center cohort of 167 patients with systemic rheumatic diseases;Rheumatology International;2024-03-29
5. Antiphospholipid syndrome, thrombosis, and vaccination in the COVID-19 pandemic;Rheumatology International;2024-02-23
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3